General Announcement::ASX:TLX; Nasdaq:TLX: Telix Beats FY24 Guidance with US$142M Q4 Revenue

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
13-Jan-2025 14:20:51
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX: Telix Beats FY24 Guidance with US$142M Q4 Revenue
Announcement Reference
SG250113OTHRUZUH
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
13/01/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX: Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Attachments

20250113 Telix Q4 Quarterly Business Update vFINAL.pdf
Total size =166K